Civic Intelligence

Every Cure Inc

EIN 92-0240717 • 501(c)3 • Philadelphia, PA

Profile

Every Cure is a nonprofit initiative on a mission to unlock the full potential of existing medicines to treat every disease and every patient they possibly can.

3675 Market Street Suite 200Philadelphia, PA 19104

www.everycure.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

22nd percentile

0.05x

Higher debt load relative to assets than 22% of similar nonprofits.

501(c)3 • $50M-$100M nonprofits • Source year 2024

Liabilities / Revenue

12th percentile

0.04x

Higher debt load relative to revenue than 12% of similar nonprofits.

501(c)3 • $50M-$100M nonprofits • Source year 2024

Net Margin

98th percentile

86%

Higher net margin than 98% of similar nonprofits.

501(c)3 • $50M-$100M nonprofits • Source year 2024

Top Officer Pay

Score unavailable

No value available

No filing with officer rows is available for this organization yet.

Asset Growth

100th percentile

1478%

Faster asset growth than 100% of similar nonprofits.

501(c)3 • $50M-$100M nonprofits • Annualized from 2023 to 2024

Revenue Growth

100th percentile

2129%

Faster revenue growth than 100% of similar nonprofits.

501(c)3 • $50M-$100M nonprofits • Annualized from 2023 to 2024

Assets

Up

$51,613,641

Up $48,343,267 (+1478%) from 2023

Liabilities

Up

$2,337,747

Up $1,371,445 (+142%) from 2023

Net Assets

Up

$49,275,894

Up $46,971,822 (+2039%) from 2023

Revenue

Up

$54,466,208

Up $52,022,823 (+2129%) from 2023

Expenses

Up

$7,434,417

Up $6,981,615 (+1542%) from 2023

Net Income

Up

$47,031,791

Up $45,041,208 (+2263%) from 2023

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$60M$40M$20M$0Assets 2022: $314,440Liabilities 2022: $0Net Assets 2022: $314,4402022Assets 2023: $3,270,374Liabilities 2023: $966,302Net Assets 2023: $2,304,0722023Assets 2024: $51,613,641Liabilities 2024: $2,337,747Net Assets 2024: $49,275,8942024

Highlighted filing

2024

Assets$51,613,641
Liabilities$2,337,747
Net Assets$49,275,894

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$60M$40M$20M$0Revenue 2022: $316,125Expenses 2022: $1,685Net Income 2022: $314,4402022Revenue 2023: $2,443,385Expenses 2023: $452,802Net Income 2023: $1,990,5832023Revenue 2024: $54,466,208Expenses 2024: $7,434,417Net Income 2024: $47,031,7912024

Highlighted filing

2024

Revenue$54,466,208
Expenses$7,434,417
Net Income$47,031,791

Filings

Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Oct 27, 2025
Return Version
2024v5.2
Gross Receipts
$54,466,208
Mission and Program Overview

Mission

Every Cure is a nonprofit initiative on a mission to unlock the full potential of existing medicines to treat every disease and every patient they possibly can.

The organization's mission is to save and improve lives by repurposing drugs.

Balance Sheet Detail
LineBeginningEndChange
Assets
Pledges and Grants Receivable$150,000$29,822,610▲ $29,672,610
Savings and Temporary Cash Investments$2,743,659$16,902,303▲ $14,158,644
Investments in Publicly Traded Securities-$4,020,121-
Cash and Non-Interest-Bearing Accounts$361,795$368,460▲ $6,665
Land, Buildings, and Equipment, Net$0$63,740▲ $63,740
Inventories for Sale or Use-$63,403-
Prepaid Expenses and Deferred Charges$5,184$40,953▲ $35,769
Total Assets$3,270,374$51,613,641▲ $48,343,267
Other Assets Total$9,736$332,051▲ $322,315
Liabilities
Accounts Payable and Accrued Expenses$284,313$2,337,747▲ $2,053,434
Deferred Revenue$681,989$0▼ $681,989
Total Liabilities$966,302$2,337,747▲ $1,371,445
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$2,185,075$48,675,894▲ $46,490,819
Net Assets With Donor Restrictions$118,997$600,000▲ $481,003
Total Net Assets Fund Balance$2,304,072$49,275,894▲ $46,971,822
Total Liabilities and Net Assets / Fund Balance$3,270,374$51,613,641▲ $48,343,267

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$63,740$12,754$76,494
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Grant MitchellCo-founder,CEO (comp 9/23-12/24)FT$448,117$17,412$465,529
David FajgenbaumPresident (comp 9/23-12/24)PT$326,793-$326,793
Mary ZuccatoCOO (comp 2/24-12/24)FT$198,737$22,827$221,564
Charlie HempsteadVP of Platform (comp 4/24-12/24)FT$172,819$29,541$202,360
Richard Jude RieseCMO (comp 7/24-11/24)FT$141,805$19,170$160,975
Adam GreenChief of Staff (comp 2/24-12/24)FT$108,000$1,938$109,938

Board Members and Trustees

NameTitle
Tanisha CarinoVice Chair
Eric HorvitzDirector
Freda Lewis-hallDirector
Janet WoodcockDirector
Robert McdonaldDirector
Tania SimoncelliDirector
Tracey SikoraCo-founder, Secretary (thru 2024)
Robert BattistaTreasurer (thru 2024)

Highest Paid Contractors

ContractorServicesLocationCompensation
Amelior Consulting LLCMatrix Consulting7503 NEWMARKET DR, Bethesda, MD 20817$189,900
Patzik Frank Samotny LtdLegal200 S WACKER DR STE 2700, Chicago, IL 60606$159,157
Revenue and Support

Revenue Composition

Contributions and Grants
$54,182,643
Program Service Revenue
$0
Investment Income
$283,565
Other Revenue
$0
All Other Contributions
$45,336,480
Change in Net Assets
$47,031,791

Noncash Contribution Practices

Property subject to holding requirements
No
Reviewed unusual noncash gifts
Yes
Third parties used for noncash contributions
No

Noncash Contributions

Contribution TypeContribution CountReported AmountValuation Method
Other Non Cash Contri Table1$108,850Fair Market Value (FMV)
Total Noncash Contributions1$108,850-

Audited Revenue Reconciliation

Revenue per Audited Statements
$54,466,208
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$23,252
Total Revenue per Audited Statements
$54,489,460
Total Revenue per Form 990
$54,466,208
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$3,148,613
Grants and Similar Amounts Paid$2,181,501
Other Expenses$2,104,303
Total Fundraising Expense$183,495
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$2,181,501--$2,181,501
Other Salaries and Wages$1,409,188$27,766$46,840$1,483,794
Current Officers, Directors, Trustees, and Key Employees$875,972$450,212-$1,326,184
Fees for Services Other$751,550$61,530$61,075$874,155
Fees for Services Legal$307,446--$307,446
Other Employee Benefits$135,400$25,143$11,428$171,971
Travel$113,459$39,278$1,312$154,049
Fees for Services Accounting-$143,309-$143,309
Payroll Taxes$83,718$23,512$5,686$112,916
Information Technology$101,268$10,560$737$112,565
Occupancy$59,628$30,340-$89,968
Pension Plan Contributions$42,611$7,586$3,551$53,748
Conferences and Meetings$14,119$17,790$72$31,981
Advertising$5,827$13,853$3,750$23,430
Fees for Services Management-$22,400-$22,400
Office Expenses$9,028$11,861-$20,889
Insurance-$15,366-$15,366
Depreciation Depletion$10,132$2,374$248$12,754
Other Expenses$5,271$349$48,734$5,620
Fees for Service Investment Mgmnt Fees-$1,631-$1,631
All Other Expenses$722$524$62$1,308
Total Functional Expenses$6,322,259$928,663$183,495$7,434,417

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Audited Statements$7,517,638
Expenses per Audited Statements$7,434,417
Total Expenses per Form 990$7,434,417
Expenses Not Reported on Form 990$83,221
Expenses Not Reported on Financial Statements$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
University of North CarolinaChapel Hill, NJ501 (c) (3)UNC WILL CO-LEAD DEVELOPMENT OF THE INTEGRATION LAYER THAT CONNECTS DIVERSE DATASETS INTO A UNIFIED BIOMEDICAL KNOWLEDGE GRAPH. THEY WILL DEFINE ONTOLOGY STANDARDS, CONDUCT MANUAL CURATION, AND LEAD HARMONIZATION ACROSS DRUG, DISEASE, AND MOLECULAR DATA TYPES. THEIR ROLE ENSURES THE ROBOKOP AND MONARCH KNOWLEDGE GRAPHS AND PROPRIETARY DATASETS ARE SYSTEMATICALLY ALIGNED TO EVERY CURE'S COMPUTATIONAL INFRASTRUCTURE.$971,372
The Scripps Research InstituteLa Jolla, CA501 (c) (3)SCRIPPS WILL INTEGRATE ITS BIOTHINGS EXPLORER PLATFORM INTO EVERY CURE'S KNOWLEDGE GRAPH, CONTRIBUTING APIS, DATA EVALUATION, AND ONTOLOGY MAPPING EXPERTISE. THEY WILL IDENTIFY PROPRIETARY DATASETS, EVALUATE THEIR UTILITY, AND REFINE INTEGRATION PROCESSES FOR CLINICAL AND PATIENT-LEVEL DATA. THEIR WORK STRENGTHENS INTEROPERABILITY AND ENSURES HIGH-VALUE BIOMEDICAL DATA IS CONNECTED ACROSS THE MATRIX PROJECT.$362,247
Institute for Systems BiologySeattle, WA501 (c) (3)ISB WILL CURATE, EVALUATE, AND INTEGRATE LARGE BIOMEDICAL DATASETS INTO EVERY CURE'S KNOWLEDGE GRAPH, FOCUSING ON DATA QUALITY AND ONTOLOGY HARMONIZATION. THEY WILL PERFORM MANUAL CURATION, CROSS-VALIDATION, AND DEVELOPMENT OF PROTOCOLS TO ENSURE RELIABLE DRUG, DISEASE, AND MOLECULAR ASSOCIATIONS. THEIR WORK ENSURES THE SPOKE DATABASE AND OTHER KEY SOURCES ARE INCORPORATED INTO A ROBUST COMPUTATIONAL FRAMEWORK FOR DRUG REPURPOSING.$309,022
Penn State UniversityUniversity Park, PA501 (c) (3)PENN STATE WILL LEAD THE DEVELOPMENT OF ADVANCED COMPUTATIONAL TOOLS, INCLUDING ALGORITHMS TO PREDICT DRUG REPURPOSING OPPORTUNITIES WITHIN THE KNOWLEDGE GRAPH. THEY WILL WORK ON DATA EXTRACTION, HARMONIZATION, AND MACHINE LEARNING MODEL DEVELOPMENT TO RANK CANDIDATE DRUGS. THEIR ROLE PROVIDES THE COMPUTATIONAL "ENGINE" THAT DRIVES PRIORITIZATION OF PROMISING THERAPIES.$303,699
University of Alabama BirminghamBirmingham, AL501 (c) (3)Uab Will Contribute Specialized Biomedical Data and Expertise in Integrating Patient-level, Genomic, and Clinical Datasets Into the Knowledge Graph. They Will Support Validation of Predicted Drug-disease Associations Through Computational and Experimental Methods. Their Work Ensures the Knowledge Graph Is Grounded in High-quality Clinical and Biological Evidence.$235,161

International Summary

Offices
1
Employees
12
Spending
$1,540,012

International Compliance

Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
United KingdomProgram ServicesResearch and Development110$1,201,883
NetherlandProgram ServicesResearch and Development02$338,129
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

Form 990 is presented during a meeting of the board of directors to each member. It is reviewed, discussed, and approved.

Form 990, Part VI, Section B, Line 12C

The organization routinely reviews any situation that arises that may cause a conflict of interest

Form 990, Part VI, Section B, Line 15

Every cure ensures that executive compensation is reasonable and competitive by following a formal, documented process. The independent directors of the board review and approve executive compensation, in line with every cure's defined compensation philosophy, on an annual basis. In accordance with the compensation philosophy, the group relies on robust sets of comparable data, including compensation studies and benchmarking from reputable databases and publicly available form 990 filings from similar organizations. The entire process, from data review to the final decision, is documented in the official meeting minutes.

Form 990, Part VI, Section C, Line 19

A packet is available upon request at the entity's office.

Form 990, Part VII - Additional Compensation Information

Grant mitchell is one of the co-founders, and the ceo. Reported compensation for 2024 includes 16 months of compensation (9/2023-12/2024), because he was paid in 2024 for 4 months of work performed in 2023 and 12 months of work performed in 2024. Annual base compensation during this time was $350,000. David fajgenbaum is one of the co-founders, and president. Reported compensation for 2024 includes 16 months of compensation (9/2023-12/2024), because he was paid in 2024 for 4 months of work performed in 2023 and 12 months of work performed in 2024. Annual base compensation during this time was $234,000. Mary zuccato is the coo. Reported compensation for 2024 includes 11 months of compensation (2/2024-12/2024), because she began work after the year began. Annual base compensation during this time was $230,000. Charlie hempstead is the vp of platform. Reported compensation includes 9 months of compensation (4/2024-12/2024), because she began work after the year began. Annual base compensation during this time was $232,750. Richard riese is the chief medical officer. Reported compensation for 2024 includes 4 months of compensation (7/2024-11/2024), because he began work after the year began and discontinued work before the year ended. Annual base compensation during this time was $350,000. Adam green is the chief of staff. Reported compensation for 2024 includes 11 months of compensation (2/2024-12/2024), because he began work after the year began. Annual base compensation during this time was $120,000.

Filing and Contact Details

Filer

Filer Name
Every Cure Inc
EIN
92-0240717
Phone
4842856568
Address
3675 MARKET STREET SUITE 200, PHILADELPHIA, PA 19104

Signing Officer

Name
David Fajgenbaum
Title
Chair, Co-founder, President
Phone
4842856568
Signed
2025-10-27
Discuss with paid preparer
Yes

Organization Details

Principal Officer
David Fajgenbaum
Formed
2022
Legal Domicile
De
Voting Board Members
8
Independent Board Members
6
Employees
16
Volunteers
9

Preparer

Firm
Sax Llp
Address
389 INTERPACE PARKWAY STE 3, PARSIPPANY, NJ 07054
Preparer
Marqus White
Phone
9734726250
Supplemental Narrative

Additional Explanations

Form 990, Part IX, Line 11G

Hr services: program service expenses 72,455. Management and general expenses 19,991. Fundraising expenses 0. Total expenses 92,446. Marketing: program service expenses 86,450. Management and general expenses 0. Fundraising expenses 0. Total expenses 86,450. Subcontracted services: program service expenses 592,645. Management and general expenses 41,539. Fundraising expenses 0. Total expenses 634,184. Strategic planning: program service expenses 0. Management and general expenses 0. Fundraising expenses 61,075. Total expenses 61,075.

FORM 990, PART XI, LINE 9:

Loss on impairment of assets held for sale -45,447.

Financial Statement Notes

PART X, LINE 2:

The organization is exempt from federal income taxes under section 501(c)(3) of the internal revenue code. In addition, the organization qualifies for the charitable contribution deduction under section 170(b)(1)(a) and has been classified as an organization that is not a private foundation under section 509(a)(2). The organization is also exempt from state income taxes within the states that the organization operates. The organization has applied the provisions of the fasb's asc 740-10, accounting for uncertainty in income taxes. Under asc 740-10, nonpublic enterprises, including nonprofit organizations, are required to record a tax liability when substantial uncertainties exist as to whether certain income is exempt from federal, state and local income tax. As of december 31, 2024, the organization had no substantial uncertain income tax positions.

PART XI, LINE 2D - OTHER ADJUSTMENTS:

Loss on impairment of assets held for sale -45,447.

Raw XML AppendixShowing 400 of 696 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt0284313
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt02337747
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0THE ORGANIZATION'S MISSION IS TO SAVE AND IMPROVE LIVES BY REPURPOSING DRUGS.
IRS990/AddressChangeInd0X
IRS990/AdvertisingGrp/FundraisingAmt03750
IRS990/AdvertisingGrp/ManagementAndGeneralAmt013853
IRS990/AdvertisingGrp/ProgramServicesAmt05827
IRS990/AdvertisingGrp/TotalAmt023430
IRS990/AllOtherContributionsAmt045336480
IRS990/AllOtherExpensesGrp/FundraisingAmt062
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt0524
IRS990/AllOtherExpensesGrp/ProgramServicesAmt0722
IRS990/AllOtherExpensesGrp/TotalAmt01308
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0MARY ZUCCATO
IRS990/BooksInCareOfDetail/PhoneNum04842856568
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt03675 MARKET STREET SUITE 200
IRS990/BooksInCareOfDetail/USAddress/CityNm0PHILADELPHIA
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd019104
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0361795
IRS990/CashNonInterestBearingGrp/EOYAmt0368460
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt02
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0450212
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0875972
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt01326184
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/FundraisingAmt072
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt017790
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt014119
IRS990/ConferencesMeetingsGrp/TotalAmt031981
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContractorCompensationGrp/CompensationAmt0189900
IRS990/ContractorCompensationGrp/CompensationAmt1159157
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt07503 NEWMARKET DR
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt1200 S WACKER DR STE 2700
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0BETHESDA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1CHICAGO
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0MD
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1IL
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd020817
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd160606
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0AMELIOR CONSULTING LLC
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt1PATZIK FRANK SAMOTNY LTD
IRS990/ContractorCompensationGrp/ServicesDesc0MATRIX CONSULTING
IRS990/ContractorCompensationGrp/ServicesDesc1LEGAL
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt054182643
IRS990/CYGrantsAndSimilarPaidAmt02181501
IRS990/CYInvestmentIncomeAmt0283565
IRS990/CYOtherExpensesAmt02104303
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt047031791
IRS990/CYSalariesCompEmpBnftPaidAmt03148613
IRS990/CYTotalExpensesAmt07434417
IRS990/CYTotalFundraisingExpenseAmt0183495
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt054466208
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd01
IRS990/DeferredRevenueGrp/BOYAmt0681989
IRS990/DeferredRevenueGrp/EOYAmt00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/FundraisingAmt0248
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt02374
IRS990/DepreciationDepletionGrp/ProgramServicesAmt010132
IRS990/DepreciationDepletionGrp/TotalAmt012754
IRS990/Desc01. AI TOOL DEVELOPMENT AND OPEN-SOURCE INITIATIVE (TECHNOLOGICAL INNOVATION)(CONTINUED ON SCHEDULE O)IN 2024, EVERY CURE'S TECHNICAL TEAM BUILT A ROBUST, SCALABLE PLATFORM TO SYSTEMATICALLY IDENTIFY HIGH-POTENTIAL DRUG REPURPOSING OPPORTUNITIES. THE TEAM CURATED COMPREHENSIVE DRUG AND DISEASE LISTS BUILDING ON EXISTING ONTOLOGIES, ESTABLISHED A POWERFUL EXPERIMENTATION AND EVALUATION INFRASTRUCTURE, AND BEGAN THE INTEGRATION OF MULTIPLE PUBLIC AND PROPRIETARY BIOMEDICAL KNOWLEDGE GRAPHS INTO A HARMONIZED ARCHITECTURE. USING THIS FOUNDATION, THEY DEVELOPED AND STABILIZED A PIPELINE THAT ENABLED RAPID, LARGE-SCALE PREDICTION OF DRUG-DISEASE MATCHES, WHICH THEN GO FOR SYSTEMATIC REVIEW BY EVERY CURE'S MEDICAL TEAM. OVER THE COURSE OF THE YEAR, THE TEAM EXECUTED AND LOGGED EIGHT EXPERIMENTS TO VALIDATE AND REFINE MODEL PERFORMANCE, SIGNIFICANTLY ACCELERATING EXPERIMENTAL THROUGHPUT INTO 2025. WE ALSO OBTAINED RIGHTS TO SEVERAL PROPRIETARY DATASETS TO IMPROVE PERFORMANCE IN DIFFERENT STAGES IN THE PIPELINE.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt0118997
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt0600000
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt016
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt04332726
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt0143309
IRS990/FeesForServicesAccountingGrp/TotalAmt0143309
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt0307446
IRS990/FeesForServicesLegalGrp/TotalAmt0307446
IRS990/FeesForServicesManagementGrp/ManagementAndGeneralAmt022400
IRS990/FeesForServicesManagementGrp/TotalAmt022400
IRS990/FeesForServicesOtherGrp/FundraisingAmt061075
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt061530
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0751550
IRS990/FeesForServicesOtherGrp/TotalAmt0874155
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt01631
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt01631
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd01
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt030.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt12.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt215.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt32.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt440.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt82.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt91.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1240.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1340.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd5X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt417412
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1022827
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1129541
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt121938
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1319170
IRS990/Form990PartVIISectionAGrp/PersonNm0DAVID FAJGENBAUM
IRS990/Form990PartVIISectionAGrp/PersonNm1TANISHA CARINO
IRS990/Form990PartVIISectionAGrp/PersonNm2TRACEY SIKORA
IRS990/Form990PartVIISectionAGrp/PersonNm3ROBERT BATTISTA
IRS990/Form990PartVIISectionAGrp/PersonNm4GRANT MITCHELL
IRS990/Form990PartVIISectionAGrp/PersonNm5FREDA LEWIS-HALL
IRS990/Form990PartVIISectionAGrp/PersonNm6ROBERT MCDONALD
IRS990/Form990PartVIISectionAGrp/PersonNm7TANIA SIMONCELLI
IRS990/Form990PartVIISectionAGrp/PersonNm8ERIC HORVITZ
IRS990/Form990PartVIISectionAGrp/PersonNm9JANET WOODCOCK
IRS990/Form990PartVIISectionAGrp/PersonNm10MARY ZUCCATO
IRS990/Form990PartVIISectionAGrp/PersonNm11CHARLIE HEMPSTEAD
IRS990/Form990PartVIISectionAGrp/PersonNm12ADAM GREEN
IRS990/Form990PartVIISectionAGrp/PersonNm13RICHARD JUDE RIESE
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0326793
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt4448117
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10198737
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt11172819
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt12108000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt13141805
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT (COMP 9/23-12/24)
IRS990/Form990PartVIISectionAGrp/TitleTxt1VICE CHAIR
IRS990/Form990PartVIISectionAGrp/TitleTxt2CO-FOUNDER, SECRETARY (THRU 2024)
IRS990/Form990PartVIISectionAGrp/TitleTxt3TREASURER (THRU 2024)
IRS990/Form990PartVIISectionAGrp/TitleTxt4CO-FOUNDER,CEO (COMP 9/23-12/24)
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10COO (COMP 2/24-12/24)
IRS990/Form990PartVIISectionAGrp/TitleTxt11VP OF PLATFORM (COMP 4/24-12/24)
IRS990/Form990PartVIISectionAGrp/TitleTxt12CHIEF OF STAFF (COMP 2/24-12/24)
IRS990/Form990PartVIISectionAGrp/TitleTxt13CMO (COMP 7/24-11/24)
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02022
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt08
IRS990/GovernmentGrantsAmt08846163
IRS990/GrantAmt02181501
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt02181501
IRS990/GrantsToDomesticOrgsGrp/TotalAmt02181501
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt054466208
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt06
IRS990/IndivRcvdGreaterThan100KCnt06
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt0737
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt010560
IRS990/InformationTechnologyGrp/ProgramServicesAmt0101268
IRS990/InformationTechnologyGrp/TotalAmt0112565
IRS990/InsuranceGrp/ManagementAndGeneralAmt015366
IRS990/InsuranceGrp/TotalAmt015366
IRS990/InventoriesForSaleOrUseGrp/EOYAmt063403
IRS990/InvestmentIncomeGrp/ExclusionAmt0283565
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0283565
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsPubTradedSecGrp/EOYAmt04020121
IRS990/IRPDocumentCnt018
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt012754
IRS990/LandBldgEquipBasisNetGrp/BOYAmt00
IRS990/LandBldgEquipBasisNetGrp/EOYAmt063740
IRS990/LandBldgEquipCostOrOtherBssAmt076494
IRS990/LegalDomicileStateCd0DE
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0EVERY CURE IS A NONPROFIT INITIATIVE ON A MISSION TO UNLOCK THE FULL POTENTIAL OF EXISTING MEDICINES TO TREAT EVERY DISEASE AND EVERY PATIENT THEY POSSIBLY CAN.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt02304072
IRS990/NetAssetsOrFundBalancesEOYAmt049275894
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0-14522
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt02185075
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt048675894
IRS990/NoncashContributionsAmt0108850
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt030340
IRS990/OccupancyGrp/ProgramServicesAmt059628
IRS990/OccupancyGrp/TotalAmt089968
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt011861
IRS990/OfficeExpensesGrp/ProgramServicesAmt09028
IRS990/OfficeExpensesGrp/TotalAmt020889
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt09736
IRS990/OtherAssetsTotalGrp/EOYAmt0332051
IRS990/OtherChangesInNetAssetsAmt0-45447
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt011428
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt025143
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0135400
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0171971
IRS990/OtherExpensesGrp/Desc0RECRUITMENT EXPENSE
IRS990/OtherExpensesGrp/Desc1MISCELLANEOUS EXPENSE
IRS990/OtherExpensesGrp/Desc2RESEARCH & DATA EXPENSE
IRS990/OtherExpensesGrp/Desc3DUES AND SUBSCRIPTION
IRS990/OtherExpensesGrp/FundraisingAmt048734
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt08122
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt115157
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt2349
IRS990/OtherExpensesGrp/ProgramServicesAmt0184659
IRS990/OtherExpensesGrp/ProgramServicesAmt1760
IRS990/OtherExpensesGrp/ProgramServicesAmt230000
IRS990/OtherExpensesGrp/ProgramServicesAmt35271
IRS990/OtherExpensesGrp/TotalAmt0192781
IRS990/OtherExpensesGrp/TotalAmt164651
IRS990/OtherExpensesGrp/TotalAmt230000
IRS990/OtherExpensesGrp/TotalAmt35620
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt046840
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt027766
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt01409188
IRS990/OtherSalariesAndWagesGrp/TotalAmt01483794
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt05686
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt023512
IRS990/PayrollTaxesGrp/ProgramServicesAmt083718
IRS990/PayrollTaxesGrp/TotalAmt0112916
IRS990/PensionPlanContributionsGrp/FundraisingAmt03551
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt07586
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt042611
IRS990/PensionPlanContributionsGrp/TotalAmt053748
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt0150000
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt029822610
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt05184
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt040953
IRS990/PrincipalOfficerNm0DAVID FAJGENBAUM
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc02. DRUG REPURPOSING RESEARCH AND DEVELOPMENT (SCIENTIFIC APPLICATION)(CONTINUED ON SCHEDULE O)EVERY CURE, INC. SAVES AND IMPROVES LIVES BY REPURPOSING DRUGS. DISCOVERY OF DRUG REPURPOSING OPPORTUNITIES OCCURS USING BOTH EXISTING KNOWLEDGE AND AI-GENERATED FINDINGS. DRUG REPURPOSING EFFORTS ENCOMPASS THE CORE SCIENTIFIC AND MEDICAL EFFORTS TO MOVE A DRUG REPURPOSING CONCEPT FROM DISCOVERY TO CLINICAL APPLICATION. ADVANCEMENT OF THE MOST PROMISING CANDIDATES MAY INCLUDE MANAGING PRE-CLINICAL STUDIES, REAL-WORLD EVIDENCE REVIEW AND CLINICAL TRIALS. IN 2024, EVERY CURE ESTABLISHED A WORLD CLASS MEDICAL TEAM, A TECHNICAL ADVISORY COUNCIL (TAC) AND A SCIENTIFIC ADVISORY COUNCIL (SAC) TO PROVIDE OVERSIGHT AND VALIDATE DISCOVERIES. THE TEAM ESTABLISHED BEST PRACTICE FOR VETTING REPURPOSING OPPORTUNITIES, LEADING TO THE IDENTIFICATION OF FOUR PROMISING REPURPOSED TREATMENTS ENDORSED BY THE SAC AS WELL AS IDENTIFICATION OF POTENTIAL THERAPEUTIC OPPORTUNITIES FOR LONG COVID. THE CANDIDATE DRUG REPURPOSING OPPORTUNITIES SPANNED CONDITIONS FROM A COMMON CANCER TO A RARE NEURODEVELOPMENTAL CONDITIONS. AS A RESULT OF THESE EFFORTS, MULTIPLE INDIVIDUALS SHARED STORIES OF HOW THEIR LIVES WERE SAVED AND IMPROVED BY REPURPOSED DRUGS.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt01844784
IRS990/ProgSrvcAccomActy3Grp/Desc03. EDUCATION AND AWARENESS-RAISING ON DRUG REPURPOSING(CONTINUED ON SCHEDULE O)EVERY CURE, INC. EDUCATES PHYSICIANS, RESEARCHERS, PATIENTS, POLICYMAKERS, AND THE GENERAL PUBLIC ABOUT THE POTENTIAL FOR DRUG REPURPOSING TO ACCELERATE CURES. EDUCATION AND OUTREACH ARE CENTRAL TO CREATING A SHIFT IN MEDICINE, WHERE EXISTING THERAPIES ARE FULLY LEVERAGED FOR DISEASES BEYOND THEIR ORIGINAL APPROVALS.SPECIFIC ACCOMPLISHMENTS INCLUDE: EDUCATIONAL PROGRAMS AND WORKSHOPS: ORGANIZED SCIENTIFIC CONVENINGS SUCH AS THE CHAN ZUCKERBERG INITIATIVE (CZI)-SUPPORTED WORKSHOP ON RARE DISEASE DRUG REPURPOSING, WHICH BROUGHT TOGETHER LEADING EXPERTS ACROSS ACADEMIA, INDUSTRY, AND GOVERNMENT TO SHARE KNOWLEDGE AND DEFINE COLLABORATIVE PATHWAYS. PROFESSIONAL OUTREACH: DISSEMINATED FINDINGS THROUGH PRESENTATIONS AT INTERNATIONAL SCIENTIFIC MEETINGS, INVITED TALKS AT RESEARCH INSTITUTIONS, AND PUBLICATION OF EDUCATIONAL CONTENT IN PROFESSIONAL OUTLETS TO INCREASE AWARENESS AMONG PHYSICIANS AND SCIENTISTS. PATIENT AND PUBLIC ENGAGEMENT: LEVERAGED MEDIA EXPOSURE, SOCIAL MEDIA CAMPAIGNS, AND DIRECT PATIENT COMMUNITY ENGAGEMENT TO INCREASE UNDERSTANDING OF DRUG REPURPOSING OPPORTUNITIES, EMPOWERING PATIENTS TO DISCUSS POTENTIAL OPTIONS WITH THEIR PHYSICIANS. ROADMAP DEVELOPMENT: ADVANCED THE ROADMAP INITIATIVE, A FRAMEWORK FOR HOW TO SYSTEMATICALLY IDENTIFY AND VALIDATE REPURPOSING OPPORTUNITIES FOR RARE DISEASES, PROVIDING A REPLICABLE RESOURCE FOR THE FIELD. DIGITAL AWARENESS: REACHED MILLIONS THROUGH MEDIA FEATURES AND SOCIAL MEDIA, HIGHLIGHTING THE STORY OF DRUG REPURPOSING AND EVERY CURE'S MISSION, INCREASING VISIBILITY AND ENGAGEMENT WITH OUR WORK.THROUGH THESE ACTIVITIES, EVERY CURE HAS CREATED A FOUNDATION OF KNOWLEDGE AND AWARENESS THAT WILL HELP TO ACCELERATE THE PACE OF DRUG REPURPOSING ACROSS THE HEALTHCARE ECOSYSTEM.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt0144749
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt02433649
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt09736
IRS990/PYOtherExpensesAmt0336135
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt01990583
IRS990/PYSalariesCompEmpBnftPaidAmt0116667
IRS990/PYTotalExpensesAmt0452802
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt02443385
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt047031791
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt02743659
IRS990/SavingsAndTempCashInvstGrp/EOYAmt016902303
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt054182643
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt02433649
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0316125
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt056932417
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0283565
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt09736
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0293301
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportTotal170Amt025965161
IRS990ScheduleA/SubstantialContributorsTotAmt030967256
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt054182643
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt02433649
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0316125
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt056932417
IRS990ScheduleA/TotalSupportAmt057225718
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/DonatedServicesAndUseFcltsAmt083221
IRS990ScheduleD/DonatedServicesUseFcltsAmt083221
IRS990ScheduleD/EquipmentGrp/BookValueAmt063740
IRS990ScheduleD/EquipmentGrp/DepreciationAmt012754
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt076494
IRS990ScheduleD/ExpensesNotReportedAmt083221
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt00
IRS990ScheduleD/ExpensesSubtotalAmt07434417
IRS990ScheduleD/FootnoteTextInd0X

Document Assets

No mirrored PDF or thumbnail assets are attached yet.